The drug, called Zolgensma and manufactured by Novartis Gene Therapies costs ₹18 crore (£1.79 million) per dose, according to the official statement UK’s National Health Service (NHS).

The drug treats Spinal Muscular Atrophy (SMA), a rare and often fatal genetic disease. The latest data suggested that Zolgensma can provide rapid and sustained improvement in motor function for young children with type 1 SMA.

The one-time gene therapy will be used to treat Spinal Muscular Atrophy (SMA) in infants. The often fatal muscle condition affects nerves in the spinal cord, leading to paralysis.

In the UK, up to 80 babies, a year are born with SMA. Children who have the most common form of it - type 1 - have a life expectancy of only two years.

Zolgensma can help babies breathe without a ventilator, sit up on their own, and crawl and walk after a single infusion treatment, as per previous studies.

The 'most expensive drug in the world' has been approved by the United Kingdom's National Health Service (NHS) to cure rare genetic disorder.

(With inputs from agencies)

The drug, called Zolgensma and manufactured by Novartis Gene Therapies costs ₹18 crore (£1.79 million) per dose, according to the official statement UK’s National Health Service (NHS).

The drug, called Zolgensma and manufactured by Novartis Gene Therapies costs ₹18 crore (£1.79 million) per dose, according to the official statement UK’s National Health Service (NHS). The drug treats Spinal Muscular Atrophy (SMA), a rare and often fatal genetic disease. The latest data suggested that Zolgensma can provide rapid and sustained improvement in motor function for young children with type 1 SMA. The one-time gene therapy will be used to treat Spinal Muscular Atrophy (SMA) in infants. The often fatal muscle condition affects nerves in the spinal cord, leading to paralysis. In the UK, up to 80 babies, a year are born with SMA. Children who have the most common form of it - type 1 - have a life expectancy of only two years. Zolgensma can help babies breathe without a ventilator, sit up on their own, and crawl and walk after a single infusion treatment, as per previous studies. The 'most expensive drug in the world' has been approved by the United Kingdom's National Health Service (NHS) to cure rare genetic disorder. (With inputs from agencies)

Zolgensma: World's most expensive drug that costs ₹18 crore a dose

German automaker Volkswagen saw net profit fall 19 per cent in the first three months of the year as it struggled to deal with a costly scandal over cars equipped to cheat on diesel emissions tests. 
The company also faced plummeting sales in Russia and Brazil due to those countries&#39; troubled economies. 
Profits for the January-March period fell to 2.37 billion euros from 2.93 billion euros a year earlier, the company said today. Revenue fell 3.4 per cent to 50.96 billion euros due in part to exchange rate effects. 
The net profit figure fell short of the 2.44 billion euros expected by analysts surveyed by financial information provider FactSet. 
Earnings and profit margins slipped at luxury brand Audi, one of the company&#39;s major money-makers. Operating profit eased to 1.3 billion euros from 1.4 billion euros a year earlier. The profit margin fell to 9.0 per cent from 9.7 per cent in the first quarter of 2015. Things went better at the company&#39;s Porsche brand. 
Operating profits, which exclude financial items such as interest and taxes, rose 14 per cent to 895 million euros. The sportscar and luxury SUV division turned in a fat profit margin of 16.6 per cent, up from 15.1 per cent. 
Sales fell 35 per cent in Russia, which has seen its currency plummet along with the price of oil, and 17 per cent in Brazil, which is in a deep recession. 
Volkswagen, based in Wolfsburg, Germany, faces heavy costs recalling and fixing cars that are equipped with engine-control software that could detect when a car was on a test stand and turned off the emissions controls during everyday driving. 
CEO Matthias Mueller said in a statement that the company &quot;managed to limit the economic effects of the diesel issue and achieve respectable results under difficult conditions.&quot; The company set aside 16.2 billion euros from its earnings last year to deal with recalls and other costs. 
The company has reached a tentative agreement in federal court in San Francisco with US authorities, who first uncovered the cheating, to buy back or repair some 500,000 vehicles. 
Volkswagen, the US Department of Justice and attorneys for Volkswagen owners have until June 21 to file a final settlement with the court. 
The company reaffirmed its forecast for the full year, saying that it expects sales revenue to fall 5 per cent for all of this year compared to 2015 and an operating return on sales of 5.0 to 6.0 per cent.(AP)

German automaker Volkswagen saw net profit fall 19 per cent in the first three months of the year as it struggled to deal with a costly scandal over cars equipped to cheat on diesel emissions tests.

German automaker Volkswagen saw net profit fall 19 per cent in the first three months of the year as it struggled to deal with a costly scandal over cars equipped to cheat on diesel emissions tests. The company also faced plummeting sales in Russia and Brazil due to those countries' troubled economies. Profits for the January-March period fell to 2.37 billion euros from 2.93 billion euros a year earlier, the company said today. Revenue fell 3.4 per cent to 50.96 billion euros due in part to exchange rate effects. The net profit figure fell short of the 2.44 billion euros expected by analysts surveyed by financial information provider FactSet. Earnings and profit margins slipped at luxury brand Audi, one of the company's major money-makers. Operating profit eased to 1.3 billion euros from 1.4 billion euros a year earlier. The profit margin fell to 9.0 per cent from 9.7 per cent in the first quarter of 2015. Things went better at the company's Porsche brand. Operating profits, which exclude financial items such as interest and taxes, rose 14 per cent to 895 million euros. The sportscar and luxury SUV division turned in a fat profit margin of 16.6 per cent, up from 15.1 per cent. Sales fell 35 per cent in Russia, which has seen its currency plummet along with the price of oil, and 17 per cent in Brazil, which is in a deep recession. Volkswagen, based in Wolfsburg, Germany, faces heavy costs recalling and fixing cars that are equipped with engine-control software that could detect when a car was on a test stand and turned off the emissions controls during everyday driving. CEO Matthias Mueller said in a statement that the company "managed to limit the economic effects of the diesel issue and achieve respectable results under difficult conditions." The company set aside 16.2 billion euros from its earnings last year to deal with recalls and other costs. The company has reached a tentative agreement in federal court in San Francisco with US authorities, who first uncovered the cheating, to buy back or repair some 500,000 vehicles. Volkswagen, the US Department of Justice and attorneys for Volkswagen owners have until June 21 to file a final settlement with the court. The company reaffirmed its forecast for the full year, saying that it expects sales revenue to fall 5 per cent for all of this year compared to 2015 and an operating return on sales of 5.0 to 6.0 per cent.(AP)

Scandal-hit Volkswagen sees profits fall in 1st quarter

costly

Costly, News on Costly, stories on Costly, articles on Costly, Costly stories at Wion, Costly news, Costly latest news